ロード中...
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
SIMPLE SUMMARY: Glioblastoma (GB) is the deadliest type of primary brain tumor. Following diagnosis the patient´s median survival is only 16 months. There are currently around 450 clinical trials focused on the development of more effective therapies for GB. Nevertheless, radiotherapy remains the mo...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867045/ https://ncbi.nlm.nih.gov/pubmed/33535436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030542 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|